American Express heads into its October 23 earnings report with the stock under meaningful pressure — down 6% on the week and 9% over the past month to $305.07 — while the Street's consensus still sits roughly 24% above the current price.
The analyst backdrop tells a cautious but not bearish story. Truist Securities trimmed its target to $370 from $375 this week, maintaining a Buy. That follows a broader wave of post-Q2 target cuts in late July, when Morgan Stanley, Evercore ISI, and BTIG all lowered their numbers after the July 24 results. The direction of travel is clear: targets are drifting down, not up, even among bulls. The mean consensus target now stands at $378, against a current price of $305 — a wide implied return that reflects genuine disagreement on whether the gap closes upward or the targets follow the stock lower. The most pointed bear on the Street, BTIG, carries a Sell with a $315 target — barely 3% above where the stock closed Tuesday. JP Morgan, which upgraded to Overweight in July with a $400 target, is the most constructive voice, but the upgrade was made at higher price levels and the stock has since retreated well past that decision point.
The core debate is straightforward. Bulls point to continued new account growth across Consumer and Commercial segments as a durable offset to slowing same-store spending, and to the fee-paying cardholder base as evidence of product demand holding up. Bears counter that new card acquisition is weakening on both a quarter-on-quarter and year-on-year basis, that the Platinum Card refresh may be masking underlying deceleration, and that the super-prime spending cohort faces headwinds from private credit market dislocations. Factor scores sit in the middle of the range: EPS surprise ranks in the 66th percentile, a solid beat track record, but forward EPS momentum on a 90-day basis has eased to just the 43rd percentile. Valuation multiples have compressed with the stock — the P/E has shed nearly two turns over the past 30 days to around 15.7x — but offer limited structural support when growth signals are mixed.
Positioning in the lending market is emphatically not the story here. Short interest amounts to just 1.5% of the free float, down 12% over the past month as shares have declined — indicating shorts have been covering into weakness rather than pressing the trade. Borrow is essentially free at 0.29%, and availability is as loose as it gets. The options market is mildly call-skewed: the put/call ratio of 0.65 is fractionally below its 20-day average of 0.68 and sits nowhere near the defensive extremes of its 52-week range. Taken together, the message from positioning is that this week's selloff is a buyer-and-holder problem, not a short-seller-driven move.
The earnings history adds a layer of sobriety. The July 24 Q2 release produced a 1.6% one-day decline and a further drift lower over five sessions. The May Q1 report saw a small positive print on day one that reversed within the week. Neither reaction was violent, but both resolved to the downside on a five-day basis — a pattern that will sit in the back of investors' minds as the October 23 date approaches.
What to watch: whether management's commentary on new card acquisition trends and billed business growth momentum gives the Street reason to rebuild targets, or whether the ongoing compression in forward estimates drags the consensus closer to the stock rather than the stock recovering toward consensus.
See the live data behind this article on ORTEX.
Open AXP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
